U.S. Department of Health and Human Services • National Institutes of Health

Advanced Search

NIAID > Health & Research Topics > Biodefense and Related Programs > Biodefense and Emerging Infectious Diseases

Skip Website Tools

Website Tools

Skip Stay Connected

Stay Connected

Social media privacy policy and disclaimers.

Could a Blood Test Predict Protective Ability of Anthrax Vaccine in Humans?

A new NIAID study suggests the TNA assay could be used in humans. Read more about this study.

You can help researchers improve public health by volunteering for NIAID clinical studies related to biodefense and emerging infectious diseases.

Additional Information From NIAID

External Resources

View a list of links for more information about biodefense and emerging infectious diseases.

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on. Read more information on enabling JavaScript.

Biodefense and Emerging Infectious Diseases

Skip Content Marketing

Share this:

NIAID’s Role in Biodefense and Emerging Infectious Diseases Research

NIAID conducts and supports basic research to better understand viruses, bacteria, and other infectious agents that cause diseases of public health concern. This research provides the foundation for developing medical products and strategies to diagnose, treat and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.

Learn more about NIAID’s Role in Biodefense and Emerging Infectious Diseases Research.